Observation {#h0.0}
===========

Pneumonia caused by *Pneumocystis jirovecii* (PCP) marked the onset of the AIDS epidemic and remains today the most frequent AIDS-defining infection as well as a major cause of mortality in immunocompromised patients ([@B1]). The poor knowledge of *P. jirovecii* biology and the absence of genome sequence are due first of all to the fact that no *in vitro* culture method is presently available. *P. jirovecii* microorganisms can be obtained only from clinical specimens of patients, thus in very limited amounts and heavily contaminated by human cells and lung flora. Here we report the assembly of the *P. jirovecii* genome sequence from a single clinical specimen of a single patient. To our knowledge, this is the first eukaryotic genome *de novo* assembled out of a metagenome.

Whole-genome sequencing requires usually between 2 to 5 µg of pure genomic DNA, which is usually not recoverable from clinical specimens without *in vitro* culture. To compensate, we used cell immunoprecipitation followed by random DNA amplification. Four bronchoalveolar lavage fluid samples (BALFs) from patients with PCP, who were all fortuitously HIV uninfected, were retained to estimate their percentages of *Pneumocystis* DNA content, two of them after enrichment in *P. jirovecii* cells using immunoprecipitation (see [Text S1](#supplS1){ref-type="supplementary-material"}, sections A1 and A4, in the supplemental material). Genomic DNA was extracted, amplified, and sequenced by low-level Roche 454 pyrosequencing. The reads from each BALF were assigned *in silico* to an organism or to a group of organisms (*Homo sapiens*, *P. jirovecii*, fungi, bacteria, or viruses), using a simplified classification pipeline (see [Text S1](#supplS1){ref-type="supplementary-material"}, section A5, in the supplemental material). This rough classification established that the enrichment was effective: the proportion of *Pneumocystis* DNA in the two enriched specimens was 23% (BALF E6) and 15% (BALF E8), whereas it was only 6% (BALF N1) and 0.7% (BALF N8) in the two nonenriched samples (see [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material).

*P. jirovecii* has been repetitively reported to be the only *Pneumocystis* species infecting humans. However, one contribution reported the presence in a single patient of *P. jirovecii* as well as *Pneumocystis carinii* ([@B2]), the species considered to infect specifically rats. To prevent any coinfections for genome sequencing, we applied an extensive verification to exclude the presence of another *Pneumocystis* species or fungus than *P. jirovecii* in the BALFs (see [Text S1](#supplS1){ref-type="supplementary-material"}, sections A6 and A7, in the supplemental material). We found that BALF E6 contained for undetermined reasons multiple *Pneumocystis* species, whereas all three other BALFs contained exclusively *P. jirovecii* (see [Table S2](#tabS2){ref-type="supplementary-material"} in the supplemental material). The rest of this study was conducted on BALF E8 with the highest load of *P. jirovecii*.

The selected BALF, E8, was from a patient with chronic lymphocytic leukemia. It was enriched in *P. jirovecii* cells, and the genomic DNA extracted from it was amplified and used for whole-genome sequencing. The major challenge in this study was the *in silico* sorting and assembly of *P. jirovecii* reads out of a mixture representing many organisms. We iteratively built stringent assembly of the reads to detect homology with the available genome of *P. carinii*, as well as with other fungal genomic data. Ideally, reads should be attributed to a single organism before an assembly of its genome is attempted. However, this simple strategy could not be applied here, as most raw reads were too short to be attributed to a taxonomic group through sequence comparison. Moreover, some *Pneumocystis*-specific reads would certainly be lost or misidentified, as *P. carinii* assembly is known to be incomplete. Hence, we have established an overall strategy for read filtration and *de novo* assembly that allowed us to progressively refine and complete the *P. jirovecii* genome (see [Text S1](#supplS1){ref-type="supplementary-material"}, section A9, and [Fig. S1](#figS1){ref-type="supplementary-material"} in the supplemental material). The rRNA unit and the mitochondrial genome were recovered, assembled, and annotated separately. The 18S nuclear rRNA subunit displayed 99% nucleotide identity with the *P. jirovecii* public sequence, providing a solid assessment of the organism identity. The repeated telomere regions that contain the major surface glycoproteins were also kept apart. The repeated regions kept apart included probably the centromeres, which were not investigated further in the absence of a genetic or physical map. *A posteriori*, 25% of the reads could be attributed to *P. jirovecii* (see [Table S3](#tabS3){ref-type="supplementary-material"} in the supplemental material). In addition, we deep sequenced total RNA isolated from a nonenriched BALF of a patient with B-cell lymphoma, which provided 2.7% of reads attributable to the fungus. The *de novo* assembly of RNAseq data yielded 2,667 transcripts, which were used for genome annotation and provided a glimpse into the fulminate infection process in the human host. As previously observed for *P. carinii* ([@B3]), the most abundant category of the transcripts was annotated as major surface glycoproteins (7.2%).

The 8.1-Mb genome assembly is made of 356 contigs ([Table 1](#tab1){ref-type="table"}). A total of 3,878 coding sequences were identified and annotated, with a gene density of 481 genes per Mbp. Seventy-seven percent of them were supported by the transcriptome data. We identified 458 single-copy orthologs that were shared by *P. jirovecii* and several other fungal species, including distantly related ascomycetes and basidiomycetes. A phylogenetic tree was computed from an alignment of these orthologous proteins ([Fig. 1](#fig1){ref-type="fig"}). It further documents the taxonomic position of *P. jirovecii* close to *P. carinii* and *Taphrina deformans.*

###### 

Statistics of *P. jirovecii* and *P. carinii* nuclear and mitochondrial genomes

  Characteristic                                Result                 
  --------------------------------------------- ---------------------- -------------------------
  Assembly                                                             
      Assembly size (Mb)                        8.1                    6.3
      Mean 454 read depth                       36                     NA[*^b^*](#ngtab1.2)
      Mean Illumina read depth                  1,315                  NA
      No. of contigs                            358                    4,278
      *N*~50~ (kb)                              41.6                   2.2
      Mean GC content (%)                       28.4                   32.5
  Annotation                                                           
      No. of CDSs                               3,898                  4,591^[*c*](#ngtab1.3)^
      Coding regions (%)                        68.9                   50.0
      No. of KEGG orthologs^[*d*](#ngtab1.4)^   269                    252
      No. of tRNA genes                         77[^*e*^](#ngtab1.0)   36^[*f*](#ngtab1.5)^
      Mean gene length (bp)                     1,472                  891
      Mean exon length (nt)                     211                    223
      Mean no. of introns per gene              4.5                    2.3
      Mean intron length (nt)                   61                     54
      Repeat density (%)                        9.86                   5.71
  Mitochondrial genome                                                 
      Assembly size (kb)                        27                     23^[*g*](#ngtab1.6)^
      No. of contigs                            3                      1
      GC content in whole genome (%)            29.5                   31.1
      GC content in coding genes (%)            32.5                   30.9
      No. of protein coding genes (CDSs)        17                     17
      No. of rRNA genes                         2                      2
      No. of tRNA genes                         12                     20

 The *P. carinii* assembly was downloaded from the *Pneumocystis* genome project website (<http://pgp.cchmc.org/>) and corresponds to the sequences published by Slaven et al. ([@B15]). This assembly is known to be incomplete.

 Not applicable.

 Some of these peptides were derived from incomplete CDSs located at the extremity of a contig. Hence, the numbers of predicted peptides provide only a rough estimation of the proteome size.

 The number of KEGG orthologs was computed as described previously (4).

 Not including pseudo tRNAs.

 Only complete copies are shown; the total number of tRNAs in the genome may be more important.

 *P. carinii* mitochondrion data were computed from the published genome (16).

![Maximum likelihood phylogeny of *P. jirovecii* and other fungi from alignment of 458 concatenated orthologs. *Rhizopus delemar* was used as the outgroup. The same tree topology was obtained using the maximum parsimony method.](mbo0061214030001){#fig1}

The most striking feature of *P. jirovecii* was the lack of certain metabolic capabilities. As we previously found in *P. carinii* ([@B4]), the category of amino acid metabolism pathways was underrepresented in *P. jirovecii* (see [Table S4](#tabS4){ref-type="supplementary-material"} in the supplemental material), and a manual analysis revealed that most enzymes specifically dedicated to the synthesis of amino acids were absent (see [Table S5](#tabS5){ref-type="supplementary-material"} in the supplemental material). The loss of these pathways is a hallmark of obligate parasites ([@B5]). This strongly suggests that *P. jirovecii* scavenges these compounds from human lungs. Accordingly, an important proportion of its genes (22%) corresponded to transporters (e.g., amino acid permeases). Such transporters are believed to be necessary in *P. carinii* for scavenging amino acids as well as other compounds, such as host cholesterol and *S*-adenosylmethionine (reviewed in reference [@B6]). The *P. jirovecii* genome presents a low GC content (29%) and a smaller size than its free-living relatives *T. deformans* and *Schizosaccharomyces pombe* (42% and 36%, 13 Mb and 14 Mb, respectively). In obligate bacterial parasites, the reduction of GC content is associated with the reduction of genome, which in turn is generally due to a loss of the genes responsible for the synthesis of compounds that can be scavenged from the host ([@B7]). *P. jirovecii* also lacks the hallmark enzymes of the glyoxylate cycle, a significant virulence factor of fungal pathogens ([@B8]), as well as polyketide synthase clusters, responsible for production of secondary metabolites, such as toxins. Together, these features are compatible with the view that *P. jirovecii* is an obligate parasite specialized in colonization of human lungs, which causes deadly disease only in immunocompromised individuals. This conclusion is further supported by the mechanism of surface antigen variation ([@B6]), the coevolution with hosts ([@B9]), and the strict host specificity of *Pneumocystis* spp. ([@B10]). Obligate parasitism also fits epidemiological studies, which failed to identify free-living forms as a source of infection. The host and reservoir of *P. jirovecii* is likely to be only humans, including immunologically impaired individuals, but also infants experiencing primo-infection ([@B11]), elderly people ([@B12]), pregnant women ([@B13]), and healthy transitory carriers ([@B14]). Consequently, the entire life cycle of *P. jirovecii* most probably takes place only within human lungs.

For an organism of clinical importance that cannot be grown in the laboratory as *P. jirovecii*, the genome sequence represents a wealth of new information for future research. It allows new analyses to be performed, such as RNA sequencing and comparative genomics, which open avenues to solve critical issues such as (i) the identification of nutritional supplements for culture *in vitro* development; (ii) the identification of new targets for development of new drugs, an important issue because only antifolates are presently efficient and development of drug resistance has been documented; and (iii) the identification of targets for the development of vaccines. The relevant *P. jirovecii* genes can now be used in these studies rather than those of *P. carinii* as models, which is particularly crucial for development of new drugs.
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